362 related articles for article (PubMed ID: 19932134)
1. Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome.
Dahlhaus R; El-Husseini A
Behav Brain Res; 2010 Mar; 208(1):96-105. PubMed ID: 19932134
[TBL] [Abstract][Full Text] [Related]
2. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
[TBL] [Abstract][Full Text] [Related]
3. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.
Pacey LK; Doss L; Cifelli C; van der Kooy D; Heximer SP; Hampson DR
Mol Cell Neurosci; 2011 Mar; 46(3):563-72. PubMed ID: 21215802
[TBL] [Abstract][Full Text] [Related]
5. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
7. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95.
Todd PK; Mack KJ; Malter JS
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14374-8. PubMed ID: 14614133
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of mTOR signaling in fragile X syndrome.
Sharma A; Hoeffer CA; Takayasu Y; Miyawaki T; McBride SM; Klann E; Zukin RS
J Neurosci; 2010 Jan; 30(2):694-702. PubMed ID: 20071534
[TBL] [Abstract][Full Text] [Related]
9. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
10. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.
Bhattacharya A; Kaphzan H; Alvarez-Dieppa AC; Murphy JP; Pierre P; Klann E
Neuron; 2012 Oct; 76(2):325-37. PubMed ID: 23083736
[TBL] [Abstract][Full Text] [Related]
11. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.
Myrick LK; Deng PY; Hashimoto H; Oh YM; Cho Y; Poidevin MJ; Suhl JA; Visootsak J; Cavalli V; Jin P; Cheng X; Warren ST; Klyachko VA
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):949-56. PubMed ID: 25561520
[TBL] [Abstract][Full Text] [Related]
12. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
Ronesi JA; Collins KA; Hays SA; Tsai NP; Guo W; Birnbaum SG; Hu JH; Worley PF; Gibson JR; Huber KM
Nat Neurosci; 2012 Jan; 15(3):431-40, S1. PubMed ID: 22267161
[TBL] [Abstract][Full Text] [Related]
13. Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice.
Santini E; Huynh TN; Longo F; Koo SY; Mojica E; D'Andrea L; Bagni C; Klann E
Sci Signal; 2017 Nov; 10(504):. PubMed ID: 29114037
[TBL] [Abstract][Full Text] [Related]
14. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
[TBL] [Abstract][Full Text] [Related]
15. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities.
Schütt J; Falley K; Richter D; Kreienkamp HJ; Kindler S
J Biol Chem; 2009 Sep; 284(38):25479-87. PubMed ID: 19640847
[TBL] [Abstract][Full Text] [Related]
16. Quantitative profiling of brain lipid raft proteome in a mouse model of fragile X syndrome.
Kalinowska M; Castillo C; Francesconi A
PLoS One; 2015; 10(4):e0121464. PubMed ID: 25849048
[TBL] [Abstract][Full Text] [Related]
17. Expression of fragile X mental retardation-1 gene with nuclear export signal mutation changes the expression profiling of mouse cerebella immortal neuronal cell.
Hu L; Chen Y; Evers S; Shen Y
Proteomics; 2005 Oct; 5(15):3979-90. PubMed ID: 16130171
[TBL] [Abstract][Full Text] [Related]
18. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
[TBL] [Abstract][Full Text] [Related]
19. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
[TBL] [Abstract][Full Text] [Related]
20. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
